Latest filing published 01 Mar 2018 for ENTELLUS MEDICAL INC, €181k.
Douglas Rohlen discloses dealings in Entellus Medical Inc to SEC (Form 4). Over a trading history stretching from 14 July 2017 to 28 February 2018, the count stands at 5 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 1 March 2018 came the latest disclosure, a transaction for €181k in Entellus Medical Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations